FXR agonist 3, an anti-NASH (Non-Alcoholic Steatohepatitis) agent, functions by activating FXR. It demonstrates anti-fibrogenic activity by inhibiting the expression of COL1A1, TGF-beta1, alpha-SMA, and TIMP1. Additionally, it significantly mitigates liver stea
Molekulargewicht:
522.43
Formel:
C28H28BrNO4
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
